Form 4 holding
Chief Business Officer
Calidi Biotherapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 471,544
- Estimated value
- $848,779
- Report date
- 12 Sep 2023
- Price
- $1.80
- Ownership
- Direct
Stephen Thesing
Insider Reports History
- Reporting-owner location
- San Diego, CA
- Latest reporting-owner signature
-
/s/ Wendy Pizarro, Attorney-in-fact for Stephen Thesing
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Stephen Thesing
Insider Reports Filed by Stephen Thesing
3
CLDI
Calidi Biotherapeutics, Inc.
- Report period
- 12 Sep 2023
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 25 Sep 2023, 18:39
- Role
- Chief Business Officer
- Next action
- Open filing details